20 Dec 2023 argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus Member news
20 Dec 2023 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301 Member news
04 Dec 2023 Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China Member news
29 Nov 2023 Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure Member news
29 Nov 2023 Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer Member news
28 Nov 2023 argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
